文献速递妇科生殖医学

先天性苗勒管异常中的子宫腺肌症:一项系统综述的发病机制启示

Adenomyosis in Congenital Müllerian Anomalies: Pathogenetic Insights From a Systematic Review
RSS 订阅 · BJOG · 2026-11-04

该系统综述检索截至2025年10月的文献,纳入42项研究共135例患者,分析子宫腺肌症在苗勒管异常各亚型中的定位及合并子宫内膜异位症的患病率。结果显示子宫腺肌症倾向于累及结构异常或梗阻的子宫腔室,子宫内膜异位症梯度与经血流出受阻相符,但证据质量低,属假说生成性。

要点

  • 单角子宫占75.6%(102/135),非交通性功能性残角子宫中子宫腺肌症累及残角10/12例(83.3%)。
  • MRKH综合征中子宫腺肌症发生于无功能性子宫内膜的残迹10/15例(66.7%)。
  • 合并子宫内膜异位症43/134例(32.1%),梗阻性异常中最常见,HWW综合征3/5例(60.0%)。

核心结论

  • 子宫腺肌症优先累及结构异常或梗阻的子宫腔室。
  • 子宫内膜异位症梯度与经血流出受阻作为共同机械决定因素相符。
  • 这些发现基于低质量证据基础,应视为假说生成性,需要前瞻性确认。

研究设计与样本

  • 系统综述,检索PubMed/MEDLINE、Embase和Scopus从建库至2025年10月,无日期限制。
  • 纳入明确描述两种疾病诊断方法的英文原始病例报告、病例系列和观察性研究。
  • 共纳入42项研究、135例患者;两名评价者独立筛选和提取数据,采用Joanna Briggs Institute工具评估方法学质量。
  • 按畸形亚型进行描述性综合,在有个体患者水平数据时进行逐例侧别分析。

主要发现

  • 单角子宫占多数(102/135,75.6%)。
  • 在直接报告定位且存在非交通性功能性残角子宫的患者中,子宫腺肌症累及残角子宫10/12例(83.3%)。
  • 在Robert子宫中,可评估的3/3例(100%)子宫腺肌症位于盲半腔同侧。
  • 在Mayer–Rokitansky–Küster–Hauser(MRKH)综合征中,子宫腺肌症发生于缺乏功能性子宫内膜的残迹10/15例(66.7%)。
  • 合并子宫内膜异位症43/134例可评估患者(32.1%),在梗阻性异常中最常见(Herlyn-Werner-Wunderlich综合征3/5例,60.0%;Robert子宫2/4例,50.0%),在纵隔子宫(0/2例,0%)和MRKH综合征(2/15例,13.3%)中最少见;在报告的梗阻性病例中,9/10例(90.0%)位于梗阻同侧。

临床怎么用

  • 作者认为这些发现可能支持提高对苗勒管异常女性、尤其是梗阻性变异型的临床意识。
  • 作者指出这些发现基于低质量证据基础,应视为假说生成性,需要前瞻性确认。

局限性

  • 这些发现基于低质量证据基础,应视为假说生成性。
  • 需要前瞻性确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Background Adenomyosis is a prevalent gynaecological disorder whose pathogenesis remains incompletely understood. Congenital Müllerian anomalies provide an informative in vivo model, since obstructive and non-obstructive variants impose spatially defined alterations of intrauterine pressure, myometrial architecture, and contractility. Objectives To characterise adenomyosis localisation across Müllerian anomaly subtypes, assess concomitant endometriosis prevalence, and examine their topographic concordance with sites of uterine obstruction. Search Strategy PubMed/MEDLINE, Embase and Scopus were searched from inception to October 2025 using MeSH/Emtree and free-text terms for adenomyosis and congenital Müllerian anomalies, without date restrictions. Selection Criteria Original case reports, case series, and observational studies in English explicitly describing the diagnostic modalities used for both conditions. Data Collection and Analysis Two reviewers independently screened and extracted data; methodological quality was assessed with the Joanna Briggs Institute tools. Data were synthesised descriptively by malformation subtype, with case-by-case laterality analysis where individual patient-level data were available. Main Results Forty-two studies (135 patients) were included. Unicornuate uterus predominated (102/135, 75.6%). Among patients with directly reported localisation and a non-communicating functional rudimentary horn, adenomyosis involved the rudimentary horn in 10/12 cases (83.3%). In Robert's uterus, adenomyosis was ipsilateral to the blind hemicavity in 3/3 evaluable cases (100%). In Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome, adenomyosis occurred in remnants lacking functional endometrium in 10/15 patients (66.7%). Concomitant endometriosis (43/134 evaluable patients, 32.1%) was most frequent in obstructive anomalies (Herlyn-Werner-Wunderlich syndrome (HWW) 3/5, 60.0%; Robert's uterus 2/4, 50.0%) and least frequent in septate uterus (0/2, 0%) and MRKH (2/15, 13.3%), localising ipsilateral to the obstruction in 9/10 (90.0%) reported obstructive cases. Conclusions Adenomyosis preferentially involved structurally abnormal or obstructed uterine compartments. The endometriosis gradient was compatible with impaired menstrual efflux as a shared mechanical determinant. These findings derive from a low-quality evidence base and should therefore be regarded as hypothesis-generating. Prospective confirmation is required, although these findings may support increased clinical awareness in women with Müllerian anomalies, particularly obstructive variants.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. BJOG:Adenomyosis in Congenital Müllerian Anomalies: Pathogenetic Insights From a Systematic Review

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。